My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 142

    1.

    EGFR associated expression profiles vary with breast tumor subtype.

    Hoadley KA, Weigman VJ, Fan C, Sawyer LR, He X, Troester MA, Sartor CI, Rieger-House T, Bernard PS, Carey LA, Perou CM.

    BMC Genomics. 2007 Jul 31;8:258.PMID: 17663798 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene expression patterns associated with p53 status in breast cancer.

    Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, Perou CM.

    BMC Cancer. 2006 Dec 6;6:276.PMID: 17150101 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.

    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.

    Cancer Res. 2006 Apr 1;66(7):3903-11.PMID: 16585219 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

    Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

    Mod Pathol. 2006 Feb;19(2):264-71.PMID: 16341146 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.

    Wang J, Barnes RO, West NR, Olson M, Chu JE, Watson PH.

    Breast Cancer Res. 2008;10(3):R51. Epub 2008 Jun 6.PMID: 18534028 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

    Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.

    PLoS One. 2009 Jul 3;4(7):e6146.PMID: 19582160 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.

    To K, Zhao Y, Jiang H, Hu K, Wang M, Wu J, Lee C, Yokom DW, Stratford AL, Klinge U, Mertens PR, Chen CS, Bally M, Yapp D, Dunn SE.

    Mol Pharmacol. 2007 Sep;72(3):641-52. Epub 2007 Jun 26.PMID: 17595327 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.

    Del Casar JM, Martín A, García C, Corte MD, Alvarez A, Junquera S, González LO, Bongera M, García-Muñiz JL, Allende MT, Vizoso F.

    Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):147-52. Epub 2008 Sep 2.PMID: 18768247 [PubMed - indexed for MEDLINE]Related articles

    9.

    Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

    Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM.

    Clin Cancer Res. 2004 Aug 15;10(16):5367-74.PMID: 15328174 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

    Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M, Tanabe KK.

    Cancer Res. 2008 Apr 1;68(7):2391-9.PMID: 18381447 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.

    Biswas DK, Iglehart JD.

    J Cell Physiol. 2006 Dec;209(3):645-52. Review.PMID: 17001676 [PubMed - indexed for MEDLINE]Related articles

    12.

    A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers.

    Creighton CJ.

    BMC Genomics. 2007 Jun 28;8:199.PMID: 17598908 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Identification of a basal-like subtype of breast ductal carcinoma in situ.

    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

    Hum Pathol. 2007 Feb;38(2):197-204.PMID: 17234468 [PubMed - indexed for MEDLINE]Related articles

    14.

    Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

    Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.

    Breast Cancer Res. 2007;9(5):R63.PMID: 17897439 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

    Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH, Byun DS, Nasser S, Arango D, Shin J, Klampfer L, Augenlicht LH, Perez-Soler R, Mariadason JM.

    Cancer Res. 2008 Mar 15;68(6):1953-61. Erratum in: Cancer Res. 2008 Aug 15;68(16):6859. Soler, Roman Perez [corrected to Perez-Soler, Roman]. PMID: 18339877 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.

    Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, Huang S, Weiss H, Rimawi M, Schiff R.

    Cancer Res. 2008 Feb 1;68(3):826-33.PMID: 18245484 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

    Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI.

    Breast Cancer Res. 2007;9(4):R50.PMID: 17686159 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics.

    Choong LY, Lim S, Loh MC, Man X, Chen Y, Toy W, Pan M, Chen CS, Poonepalli A, Hande MP, Tan PH, Salto-Tellez M, Wong CY, Shah N, Druker BJ, Lim YP.

    Mol Cancer Ther. 2007 Nov;6(11):2828-42. Epub 2007 Nov 7.PMID: 17989321 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women.

    Nalwoga H, Arnes JB, Wabinga H, Akslen LA.

    APMIS. 2008 Jun;116(6):515-25.PMID: 18754326 [PubMed - indexed for MEDLINE]Related articles

    20.

    DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

    Roll JD, Rivenbark AG, Jones WD, Coleman WB.

    Mol Cancer. 2008 Jan 25;7:15.PMID: 18221536 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity